Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A randomized comparison of HBP versus RVP: Effect on left ventricular function and biomarkers of collagen metabolism

J. Mizner, P. Waldauf, D. Grieco, H. Linkova, O. Ionita, P. Vijayaraman, R. Petr, R. Raková, J. Vesela, P. Stros, D. Herman, P. Osmancik, K. Curila

. 2023 ; 81 (5) : 472-481. [pub] 20230316

Jazyk angličtina Země Polsko

Typ dokumentu randomizované kontrolované studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010729

BACKGROUND: Right ventricular pacing (RVP) can result in pacing-induced cardiomyopathy (PICM). It is unknown whether specific biomarkers reflect differences between His bundle pacing (HBP) and RVP and predict a decrease in left ventricular function during RVP. AIMS: We aimed to compare the effect of HBP and RVP on the left ventricular ejection fraction (LVEF) and to study how they affect serum markers of collagen metabolism. METHODS: Ninety-two high-risk PICM patients were randomized to HBP or RVP groups. Their clinical characteristics, echocardiography, and serum levels of transforming growth factor β1 (TGF-β1), matrix metalloproteinase 9 (MMP-9), suppression of tumorigenicity 2 interleukin (ST2-IL), tissue inhibitor of metalloproteinase 1 (TIMP-1), and galectin 3 (Gal-3) were studied before pacemaker implantation and six months later. RESULTS: Fifty-three patients were randomized to the HBP group and 39 patients to the RVP group. HBP failed in 10 patients, who crossed over to the RVP group. Patients with RVP had significantly lower LVEF compared to HBP patients after six months of pacing (-5% and -4% in as-treated and intention-to-treat analysis, respectively). Levels of TGF-β1 after 6 months were lower in HBP than RVP patients (mean difference -6 ng/ml; P = 0.009) and preimplant Gal-3 and ST2-IL levels were higher in RVP patients, with a decline in LVEF ≥5% compared to those with a decline of <5% (mean difference 3 ng/ml and 8 ng/ml; P = 0.02 for both groups). CONCLUSION: In high-risk PICM patients, HBP was superior to RVP in providing more physiological ventricular function, as reflected by higher LVEF and lower levels of TGF-β1. In RVP patients, LVEF declined more in those with higher baseline Gal-3 and ST2-IL levels than in those with lower levels.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010729
003      
CZ-PrNML
005      
20230801132614.0
007      
ta
008      
230718s2023 pl f 000 0|eng||
009      
AR
024    7_
$a 10.33963/KP.a2023.0065 $2 doi
035    __
$a (PubMed)36929298
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Mizner, Jan $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic. karol.curila@fnkv.cz
245    12
$a A randomized comparison of HBP versus RVP: Effect on left ventricular function and biomarkers of collagen metabolism / $c J. Mizner, P. Waldauf, D. Grieco, H. Linkova, O. Ionita, P. Vijayaraman, R. Petr, R. Raková, J. Vesela, P. Stros, D. Herman, P. Osmancik, K. Curila
520    9_
$a BACKGROUND: Right ventricular pacing (RVP) can result in pacing-induced cardiomyopathy (PICM). It is unknown whether specific biomarkers reflect differences between His bundle pacing (HBP) and RVP and predict a decrease in left ventricular function during RVP. AIMS: We aimed to compare the effect of HBP and RVP on the left ventricular ejection fraction (LVEF) and to study how they affect serum markers of collagen metabolism. METHODS: Ninety-two high-risk PICM patients were randomized to HBP or RVP groups. Their clinical characteristics, echocardiography, and serum levels of transforming growth factor β1 (TGF-β1), matrix metalloproteinase 9 (MMP-9), suppression of tumorigenicity 2 interleukin (ST2-IL), tissue inhibitor of metalloproteinase 1 (TIMP-1), and galectin 3 (Gal-3) were studied before pacemaker implantation and six months later. RESULTS: Fifty-three patients were randomized to the HBP group and 39 patients to the RVP group. HBP failed in 10 patients, who crossed over to the RVP group. Patients with RVP had significantly lower LVEF compared to HBP patients after six months of pacing (-5% and -4% in as-treated and intention-to-treat analysis, respectively). Levels of TGF-β1 after 6 months were lower in HBP than RVP patients (mean difference -6 ng/ml; P = 0.009) and preimplant Gal-3 and ST2-IL levels were higher in RVP patients, with a decline in LVEF ≥5% compared to those with a decline of <5% (mean difference 3 ng/ml and 8 ng/ml; P = 0.02 for both groups). CONCLUSION: In high-risk PICM patients, HBP was superior to RVP in providing more physiological ventricular function, as reflected by higher LVEF and lower levels of TGF-β1. In RVP patients, LVEF declined more in those with higher baseline Gal-3 and ST2-IL levels than in those with lower levels.
650    _2
$a lidé $7 D006801
650    12
$a funkce levé komory srdeční $x fyziologie $7 D016277
650    _2
$a tepový objem $x fyziologie $7 D013318
650    _2
$a transformující růstový faktor beta1 $7 D053773
650    _2
$a interleukin-1 receptor-like 1 protein $7 D000072179
650    _2
$a tkáňový inhibitor metaloproteinasy 1 $7 D019715
650    _2
$a kardiostimulace umělá $x škodlivé účinky $7 D002304
650    12
$a kardiomyopatie $7 D009202
650    _2
$a biologické markery $7 D015415
650    _2
$a kolagen $7 D003094
650    _2
$a Hisův svazek $7 D002036
650    _2
$a výsledek terapie $7 D016896
650    _2
$a elektrokardiografie $7 D004562
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Waldauf, Petr $u Department of Anesthesia and Intensive Care, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Grieco, Domenico $u Department of Cardiology, Policlinico Casilino of Rome, Rome, Italy
700    1_
$a Linkova, Hana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Ionita, Oana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Vijayaraman, Pugazhendhi $u Geisinger Heart Institute, Wilkes Barre, Pennsylvania, United States
700    1_
$a Petr, Robert $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Raková, Radka $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Vesela, Jana $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Stros, Petr $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Herman, Dalibor $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Osmancik, Pavel $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
700    1_
$a Curila, Karol $u Cardiocenter, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic
773    0_
$w MED00003056 $t Kardiologia polska $x 1897-4279 $g Roč. 81, č. 5 (2023), s. 472-481
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36929298 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801132611 $b ABA008
999    __
$a ok $b bmc $g 1963275 $s 1196994
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 81 $c 5 $d 472-481 $e 20230316 $i 1897-4279 $m Kardiologia Polska $n Kardiol Pol $x MED00003056
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...